GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+2.98%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$207M
AUM Growth
+$207M
(-6.8%)
Cap. Flow
-$25.4M
Cap. Flow
% of AUM
-12.31%
Top 10 Holdings %
Top 10 Hldgs %
75.9%
Holding
44
New
8
Increased
5
Reduced
10
Closed
15
Top Buys
| 1 |
CNXR
Connecture, Inc.
CNXR
|
$49.6M |
| 2 |
Arrowhead Research
ARWR
|
$8.32M |
| 3 |
Theriva Biologics
TOVX
|
$5.84M |
| 4 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$4.9M |
| 5 |
AGEN
Agenus
AGEN
|
$3.65M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$18.2M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11.7M |
| 3 |
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
|
$9.24M |
| 4 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$8.02M |
| 5 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$7.5M |
Sector Composition
| 1 | Healthcare | 52.14% |
| 2 | Technology | 23.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNXR
1
DELISTED
Connecture, Inc.
CNXR
| $49.6M | 23.86% | +5,502,965 | New | +$49.6M |
|
|
HPTX
2
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $24M | 11.53% | 998,066 +204,202 | +26% | +$4.9M |
|
|
ALIM
3
DELISTED
Alimera Sciences, Inc.
ALIM
| $14.5M | 6.99% | 2,619,853 | – | – |
|
|
OCRX
4
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $12.5M | 6.02% | 1,963,778 +104,463 | +6% | +$665K |
|
|
DSCI
5
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $11M | 5.31% | 1,185,632 +24,028 | +2% | +$224K |
|
|
INFI
6
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $10.6M | 5.08% | 625,000 -475,000 | -43% | -$8.02M |
|
|
ELGX
7
DELISTED
Endologix Inc
ELGX
| $9.94M | 4.78% | 650,000 -323,200 | -33% | -$4.94M |
|
8
Aurinia Pharmaceuticals
AUPH
$1.58B
| $8.88M | 4.28% | 2,485,576 +11,500 | +0.5% | +$41.1K |
|
|
9
Arrowhead Research
ARWR
$3.05B
| $8.32M | 4% | +1,126,835 | New | +$8.32M |
|
|
ARDM
10
DELISTED
Aradigm Corp Common Stock
ARDM
| $7.62M | 3.67% | 1,002,962 -5,100 | -0.5% | -$38.8K |
|
11
Emergent Biosolutions
EBS
$443M
| $6.81M | 3.28% | 250,000 -40,000 | -14% | -$1.09M |
|
12
Vericel Corp
VCEL
$1.83B
| $6.6M | 3.18% | 2,170,000 | – | – |
|
|
13
Theriva Biologics
TOVX
$3.94M
| $5.84M | 2.81% | +3,998,941 | New | +$5.84M |
|
14
Veracyte
VCYT
$2.39B
| $5.36M | 2.58% | 554,426 -52,870 | -9% | -$511K |
|
15
Tenax Therapeutics
TENX
$27.3M
| $4.26M | 2.05% | 1,108,593 -6,904 | -0.6% | -$26.5K |
|
|
AGEN
16
Agenus
AGEN
$133M
| $3.65M | 1.76% | +920,300 | New | +$3.65M |
|
17
Orthofix Medical
OFIX
$592M
| $3.31M | 1.59% | 110,000 -154,873 | -58% | -$4.66M |
|
18
Exelixis
EXEL
$10.1B
| $3.22M | 1.55% | 2,233,711 -2,866,289 | -56% | -$4.13M |
|
|
ADMS
19
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $2.97M | 1.43% | +170,816 | New | +$2.97M |
|
|
FRTX
20
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $2.22M | 1.07% | 2,117,941 -907,059 | -30% | -$952K |
|
21
Traws Pharma
TRAW
$9.89M
| $1.82M | 0.88% | 553,079 +207,255 | +60% | +$682K |
|
|
BLCM
22
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.15M | 0.55% | +50,000 | New | +$1.15M |
|
23
MEI Pharma
MEIP
$160M
| $673K | 0.32% | 157,661 | – | – |
|
|
STRM
24
DELISTED
Streamline Health Solutions
STRM
| $656K | 0.32% | 151,611 | – | – |
|
|
ZGNX
25
DELISTED
Zogenix, Inc.
ZGNX
| $503K | 0.24% | +367,502 | New | +$503K |
|